Publications by authors named "Angela Y Men"

Claim this Profile
E
Extrapolation of Efficacy from Adults to Pediatric Patients of Drugs for Treatment of Partial Onset Seizures: A Regulatory Perspective.
Shailly Mehrotra, Atul Bhattaram, Kevin Krudys, Michael Bewernitz, Ramana Uppoor, Angela Yuxin Men

Clin Pharmacol Ther· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical pharmacology as a cornerstone of orphan drug development.
Edward D Bashaw, Shiew-Mei Huang, Timothy R Coté, Anne R Pariser, Christine E Garnett, Angela Y Men

Nat Rev Drug Discov· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CYP-mediated therapeutic protein-drug interactions: clinical findings, proposed mechanisms and regulatory implications.
Jang-Ik Lee, Lei Zhang, Angela Y Men, Leslie A Kenna, Shiew-Mei Huang

Clin Pharmacokinet· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fixed dosing versus body size-based dosing of monoclonal antibodies in adult clinical trials.
Diane D Wang, Shuzhong Zhang, Hong Zhao, Angela Y Men, Kourosh Parivar

J Clin Pharmacol· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
U.S. Food and Drug Administration approval: panitumumab for epidermal growth factor receptor-expressing metastatic colorectal carcinoma with progression following fluoropyrimidine-, oxaliplatin-, and irinotecan-containing chemotherapy regimens.
Ruthann M Giusti, Kaushikkumar Shastri, Anne M Pilaro, Chana Fuchs, Ruth Cordoba-Rodriguez, Angela Yuxin Men

Clin Cancer Res· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis